Grown Rogue International Inc. Files 20-F for Fiscal Year Ended October 31, 2023

Ticker: GRUSF · Form: 20-F · Filed: Mar 13, 2024 · CIK: 1463000

Grown Rogue International Inc. 20-F Filing Summary
FieldDetail
CompanyGrown Rogue International Inc. (GRUSF)
Form Type20-F
Filed DateMar 13, 2024
Risk Levellow
Pages15
Reading Time18 min
Sentimentneutral

Sentiment: neutral

Topics: Grown Rogue International, 20-F Filing, Annual Report, Agriculture, Financials

TL;DR

<b>Grown Rogue International Inc. has submitted its 20-F annual report for the fiscal year ending October 31, 2023.</b>

AI Summary

Grown Rogue International Inc. (GRUSF) filed a Foreign Annual Report (20-F) with the SEC on March 13, 2024. Grown Rogue International Inc. filed its annual report on Form 20-F for the fiscal year ended October 31, 2023. The filing covers the period from November 1, 2022, to October 31, 2023. The company's principal business address is 550 Airport Road, Medford, OR 97504. Grown Rogue International Inc. was formerly known as Novicius Corp., Intelligent Content Enterprises Inc., and Eagleford Energy Corp. The company is classified under AGRICULTURE PRODUCTION - CROPS with SIC code 0100.

Why It Matters

For investors and stakeholders tracking Grown Rogue International Inc., this filing contains several important signals. This filing provides a comprehensive overview of the company's financial performance and business operations for the past fiscal year, crucial for investors assessing its current standing. As a foreign private issuer, the 20-F filing is the primary disclosure document for Grown Rogue International Inc., offering insights into its governance, risk factors, and financial health.

Risk Assessment

Risk Level: low — Grown Rogue International Inc. shows low risk based on this filing. The risk level is assessed as low because the filing is a standard annual report (20-F) and does not contain immediate, significant negative news or financial distress indicators within the provided metadata.

Analyst Insight

Review the full 20-F filing to understand Grown Rogue International Inc.'s financial performance, strategic initiatives, and risk factors for the fiscal year ended October 31, 2023.

Key Numbers

  • 2023-10-31 — Fiscal Year End (Conformed period of report)
  • 2024-03-13 — Filing Date (Filed as of date)
  • 000-53646 — SEC File Number (SEC file number)
  • 0001463000 — Central Index Key (Central Index Key)

Key Players & Entities

  • Grown Rogue International Inc. (company) — Filer name
  • Novicius Corp. (company) — Former company name
  • Intelligent Content Enterprises Inc. (company) — Former company name
  • Eagleford Energy Corp. (company) — Former company name
  • 550 Airport Road, Medford, OR 97504 (address) — Business address

FAQ

When did Grown Rogue International Inc. file this 20-F?

Grown Rogue International Inc. filed this Foreign Annual Report (20-F) with the SEC on March 13, 2024.

What is a 20-F filing?

A 20-F is a annual report for foreign private issuers, equivalent to a 10-K but following international reporting standards. This particular 20-F was filed by Grown Rogue International Inc. (GRUSF).

Where can I read the original 20-F filing from Grown Rogue International Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Grown Rogue International Inc..

What are the key takeaways from Grown Rogue International Inc.'s 20-F?

Grown Rogue International Inc. filed this 20-F on March 13, 2024. Key takeaways: Grown Rogue International Inc. filed its annual report on Form 20-F for the fiscal year ended October 31, 2023.. The filing covers the period from November 1, 2022, to October 31, 2023.. The company's principal business address is 550 Airport Road, Medford, OR 97504..

Is Grown Rogue International Inc. a risky investment based on this filing?

Based on this 20-F, Grown Rogue International Inc. presents a relatively low-risk profile. The risk level is assessed as low because the filing is a standard annual report (20-F) and does not contain immediate, significant negative news or financial distress indicators within the provided metadata.

What should investors do after reading Grown Rogue International Inc.'s 20-F?

Review the full 20-F filing to understand Grown Rogue International Inc.'s financial performance, strategic initiatives, and risk factors for the fiscal year ended October 31, 2023. The overall sentiment from this filing is neutral.

How does Grown Rogue International Inc. compare to its industry peers?

Grown Rogue International Inc. operates within the AGRICULTURE PRODUCTION - CROPS sector.

Are there regulatory concerns for Grown Rogue International Inc.?

The company is filing a Form 20-F, which is an annual report required for foreign private issuers under the Securities Exchange Act of 1934.

Industry Context

Grown Rogue International Inc. operates within the AGRICULTURE PRODUCTION - CROPS sector.

Regulatory Implications

The company is filing a Form 20-F, which is an annual report required for foreign private issuers under the Securities Exchange Act of 1934.

What Investors Should Do

  1. Analyze the financial statements within the 20-F for revenue, net income, and other key financial metrics.
  2. Review the 'Risk Factors' section to understand potential challenges and uncertainties facing the company.
  3. Examine the Management's Discussion and Analysis of Financial Condition and Results of Operations for insights into business strategy and performance drivers.

Year-Over-Year Comparison

This is the initial filing data provided for the fiscal year ended October 31, 2023. Comparative data from the previous year's filing is not available in this extract.

Filing Stats: 4,501 words · 18 min read · ~15 pages · Grade level 12.5 · Accepted 2024-03-13 17:17:53

Filing Documents

RISK FACTORS

RISK FACTORS 2 ITEM 4 INFORMATION ON THE COMPANY 15 A. HISTORY AND DEVELOPMENT OF THE COMPANY 15 B. BUSINESS OVERVIEW 19 C. ORGANIZATIONAL STRUCTURE 24 D. PROPERTY, PLANTS AND EQUIPMENT 25 ITEM 4A UNRESOLVED STAFF COMMENTS 26 ITEM 5 OPERATING AND FINANCIAL REVIEW AND PROSPECTS 26 A. OPERATING RESULTS 35 B. LIQUIDITY AND CAPITAL RESOURCES 39 C. RESEARCH AND DEVELOPMENT, PATENTS AND LICENSES 41 D. TREND INFORMATION 41 E. CRITICAL ACCOUNTING ESTIMATES 42 ITEM 6 DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 42 A. DIRECTORS AND SENIOR MANAGEMENT 42 B. COMPENSATION 44 C. BOARD PRACTICES 47 D. EMPLOYEES 54 E. SHARE OWNERSHIP 54 ITEM 7 MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 55 A. MAJOR SHAREHOLDERS 55 B. RELATED PARTY TRANSACTIONS 56 C. INTERESTS OF EXPERTS AND COUNSEL 57 ITEM 8 FINANCIAL INFORMATION 58 A. CONSOLIDATED STATEMENTS AND OTHER FINANCIAL INFORMATION 58 B. SIGNIFICANT CHANGES 58 ITEM 9 THE OFFER AND LISTING 58 A. OFFER AND LISTING DETAILS 58 B. PLAN OF DISTRIBUTION 59 C. MARKETS 59 D. SELLING SHAREHOLDERS 59 E.

DILUTION

DILUTION 59 F. EXPENSES OF THE ISSUE 59 i Table of Contents ITEM 10 ADDITIONAL INFORMATION 59 A. SHARE CAPITAL 59 B. MEMORANDUM AND ARTICLES OF ASSOCIATION 59 C. MATERIAL CONTRACTS 66 D. EXCHANGE CONTROLS 68 E. TAXATION 69 F. DIVIDENDS AND PAYING AGENTS 72 G. 72 H. DOCUMENTS ON DISPLAY 72 I. SUBSIDIARY INFORMATION 72 ITEM 11 QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK 73 ITEM 12

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 73 A. DEBT SECURITIES 73 B. WARRANTS AND RIGHTS 73 C. OTHER SECURITIES 73 D. AMERICAN DEPOSITORY SHARES 73 PART II 74 ITEM 13 DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 74 ITEM 14 MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 74 ITEM 15

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 74 ITEM 16 [RESERVED] 75 ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 75 ITEM 16B. CODE OF ETHICS 75 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 76 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 77 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 77 ITEM 16F. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT 77 ITEM 16G. CORPORATE GOVERNANCE 78 ITEM 16H. MINE SAFETY DISCLOSURE 78 ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION 78 PART III 79 ITEM 17

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 79 ITEM 18

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 79 ITEM 19 EXHIBITS 80 ii Table of Contents GENERAL In this Annual Report, references to "we", "us", "our", the "Company", and "Grown Rogue" means Grown Rogue International Inc., and its subsidiaries, unless the context requires otherwise. We use the United States dollar as our reporting and presentation currency and our consolidated financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB"). All monetary references in this document are to U.S. dollars, unless otherwise indicated. All references in this document to "dollars" or "

quot; or "U.S.
quot; mean United States dollars, unless otherwise indicated, and references to "CAD
quot; mean Canadian dollars. NOTE REGARDING FORWARD-LOOKING STATEMENTS Much of the information included in this Form 20-F ("Report") is based upon estimates, projections or other "forward-looking statements". Such forward-looking statements include any projections or estimates made by us and our management in connection with our business operations. These statements relate to future events or our future financial performance. In some cases you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of those terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Such estimates, projections or other forward-looking statements involve various risks and uncertainties and other factors, including the risks in the section titled "Risk Factors"

RISK FACTORS

RISK FACTORS In addition to the other information presented in this Report, the following risk factors should be given special consideration when evaluating an investment in our securities. THERE ARE NUMEROUS AND VARIED RISKS, KNOWN AND UNKNOWN, THAT MAY PREVENT US FROM ACHIEVING OUR GOALS. THE RISKS DESCRIBED BELOW ARE NOT THE ONLY ONES WE WILL FACE. IF ANY OF THESE RISKS ACTUALLY OCCURS, OUR BUSINESS, FINANCIAL CONDITION OR RESULTS OF OPERATION MAY BE MATERIALLY ADVERSELY AFFECTED. IN SUCH CASE, THE TRADING PRICE OF OUR SECURITIES COULD DECLINE AND INVESTORS IN OUR SECURITIES COULD LOSE ALL OR PART OF THEIR INVESTMENT. THE INFORMATION IN THIS REPORT IS COMPLETE AND ACCURATE AS OF THE DATES REFERENCED HEREIN, BUT THE INFORMATION MAY CHANGE AFTER SUCH DATE. SHOULD ONE OR MORE OF THE FOLLOWING RISKS OR UNCERTAINTIES MATERIALIZE, OR SHOULD THE UNDERLYING ASSUMPTIONS OF OUR BUSINESS PROVE INCORRECT, ACTUAL RESULTS MAY DIFFER SIGNIFICANTLY FROM THOSE ANTICIPATED, BELIEVED, ESTIMATED, EXPECTED, INTENDED OR PLANNED. 2 Table of Contents Risks Factors Relating to Our Business Business is Illegal under U.S. Federal Law. The Company, through its subsidiaries, engages in the medical and adult-use marijuana industry in the United States where local state law permits such activities. Producing, manufacturing, processing, possessing, distributing, selling, and using marijuana is a federal crime in the United States. The United States federal government regulates drugs through the Controlled Substances Act (the "Federal CSA"), which places controlled substances, including cannabis, on one of five schedules. Cannabis is currently classified as a Schedule I controlled substance, which is viewed as having a high potential for abuse and having no currently accepted medical use in treatment in the United States. No prescriptions may be written for Schedule I substances, and such substances are subject to production quotas imposed by the United States Drug Enforcement Adminis

View Full Filing

View this 20-F filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.